🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 17 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/08/2010 | 33,86 | 33,96 | 33,43 | 33,75 | -0,48% | 1,58% | 9.571.174 |
| 17/08/2010 | 33,58 | 33,99 | 33,34 | 33,91 | +1,63% | 1,93% | 11.189.496 |
| 16/08/2010 | 33,18 | 33,40 | 33,01 | 33,37 | -0,09% | 1,18% | 7.217.052 |
| 13/08/2010 | 33,21 | 33,54 | 33,06 | 33,40 | -0,11% | 1,44% | 9.172.306 |
| 12/08/2010 | 33,06 | 33,64 | 33,02 | 33,44 | +0,43% | 1,88% | 9.597.479 |
| 11/08/2010 | 33,69 | 33,87 | 33,23 | 33,29 | -2,46% | 1,93% | 13.039.321 |
| 10/08/2010 | 33,59 | 34,34 | 33,23 | 34,13 | +1,16% | 3,32% | 12.434.206 |
| 09/08/2010 | 33,45 | 33,82 | 33,45 | 33,74 | +1,09% | 1,08% | 10.796.496 |
| 06/08/2010 | 33,23 | 33,40 | 32,92 | 33,38 | -0,26% | 1,44% | 12.218.422 |
| 05/08/2010 | 33,40 | 33,55 | 33,11 | 33,46 | -0,34% | 1,31% | 10.545.710 |
| 04/08/2010 | 33,19 | 33,64 | 32,97 | 33,58 | +1,06% | 2,01% | 13.764.013 |
| 03/08/2010 | 33,49 | 33,64 | 32,90 | 33,23 | -0,71% | 2,19% | 15.282.146 |
| 02/08/2010 | 33,26 | 33,51 | 32,97 | 33,46 | +1,77% | 1,64% | 12.688.031 |
| 30/07/2010 | 32,78 | 33,04 | 32,27 | 32,88 | -1,71% | 2,36% | 22.764.656 |
| 29/07/2010 | 33,40 | 33,68 | 33,02 | 33,45 | +0,92% | 2,00% | 15.270.722 |
| 28/07/2010 | 33,53 | 33,79 | 33,03 | 33,15 | -1,25% | 2,25% | 10.175.870 |
| 27/07/2010 | 33,70 | 33,96 | 33,40 | 33,57 | -0,26% | 1,67% | 13.285.810 |
| 26/07/2010 | 33,40 | 33,68 | 33,22 | 33,65 | +1,15% | 1,40% | 10.096.956 |
| 23/07/2010 | 33,56 | 33,56 | 32,83 | 33,27 | -0,88% | 2,16% | 16.431.802 |
| 22/07/2010 | 33,74 | 33,89 | 33,40 | 33,57 | -0,03% | 1,47% | 16.482.944 |
| 21/07/2010 | 33,86 | 34,06 | 33,38 | 33,58 | -1,32% | 2,00% | 13.429.491 |
| 20/07/2010 | 33,89 | 34,03 | 33,59 | 34,03 | -0,39% | 1,29% | 14.684.262 |
| 19/07/2010 | 34,29 | 34,46 | 34,06 | 34,16 | -0,31% | 1,17% | 10.604.188 |
| 16/07/2010 | 34,86 | 35,11 | 34,24 | 34,27 | -1,59% | 2,52% | 17.374.792 |
| 15/07/2010 | 34,59 | 34,89 | 34,26 | 34,82 | +0,80% | 1,82% | 11.518.673 |
| 14/07/2010 | 34,55 | 34,70 | 34,19 | 34,54 | -0,69% | 1,49% | 11.736.657 |
| 13/07/2010 | 34,48 | 35,02 | 34,38 | 34,78 | +1,00% | 1,85% | 13.523.497 |
| 12/07/2010 | 34,54 | 34,58 | 34,20 | 34,44 | -0,58% | 1,11% | 13.223.245 |
| 09/07/2010 | 34,27 | 34,73 | 34,08 | 34,64 | +1,23% | 1,89% | 12.569.083 |
| 08/07/2010 | 34,23 | 34,23 | 33,71 | 34,22 | +1,21% | 1,51% | 16.314.426 |